Welcome to our dedicated page for Atlantic Intl SEC filings (Ticker: ATLN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Atlantic International Corp’s filings rarely fit a single mold—one page dissects True Single Molecule Sequencing R&D, the next outlines Lyneer Staffing’s nationwide head-count costs. If you have struggled to reconcile these moving parts, you are not alone. Stock Titan gathers every Atlantic International Corp SEC filing in real time and lets our AI break down the details you actually care about.
Need the Atlantic International Corp quarterly earnings report 10-Q filing to compare staffing gross margins with genomics grant revenue? Our dashboard delivers it the moment EDGAR releases. Curious about Atlantic International Corp insider trading Form 4 transactions before a new acquisition? Instant alerts track each executive stock move, while concise summaries flag trends. From an Atlantic International Corp 8-K material events explained note on a sudden partnership to the fine print of an Atlantic International Corp proxy statement executive compensation, our AI writes plain-language highlights so you can focus on decisions, not page counts.
Here is what you will find:
- 10-K annual report—get the Atlantic International Corp annual report 10-K simplified with segmented revenue, R&D outlays, and liquidity analysis in minutes.
- 10-Q quarterly update—AI-assisted variance tables and Atlantic International Corp earnings report filing analysis for each business line.
- Form 4 insider alerts—Atlantic International Corp Form 4 insider transactions real-time plus historical trend visuals.
- 8-K material events—critical disclosures parsed so you understand impacts immediately.
Whether you are understanding Atlantic International Corp SEC documents with AI for strategic positioning or monitoring Atlantic International Corp executive stock transactions Form 4 ahead of market moves, Stock Titan turns dense filings into actionable clarity.
Atlantic International Corp. reported that Michael Tenore, General Counsel and an officer, was awarded 264,860 restricted shares on 08/11/2025 following a board review of senior management equity tied to the June 18, 2024 closing of the Lyneer Investments LLC acquisition.
The award carries a nominal conversion price of $0.0001, becomes exercisable or vests on 01/01/2026, does not have an expiration date, and raises Tenore’s reported beneficial ownership to 842,031 shares. The Form 4 records this as a direct acquisition of derivative securities converted into common stock.
Atlantic International Corp.'s Chief Executive Officer Jeffrey M. Jagid reported changes in beneficial ownership on Form 4. On 08/11/2025 Mr. Jagid gifted 200,000 shares to each of his two brothers (total 400,000 shares) in transactions exempt from Section 16(b); after the gift his reported direct common stock holdings were 3,335,169 shares. The Board awarded him a Restricted Stock Award of 1,000,000 shares on 08/11/2025 with a nominal price of $0.0001 and an exercisable/vesting date of 01/04/2026; the award has no expiration. Following the award, his reported beneficial ownership rose to 3,885,856 shares. The Form is signed 08/13/2025.
This Form 4/A filing reports an amended insider trading activity for Christopher Broderick, Chief Financial Officer of Atlantic International Corp (ATLN). The amendment corrects a transaction originally filed on January 8, 2025.
Key transaction details:
- On January 7, 2025, Broderick acquired 577,171 shares of common stock at $0.0001 per share
- Following the transaction, Broderick directly owned 2,004,237 shares
- Additionally, Broderick was granted 577,171 Restricted Stock Units (RSUs) with an exercise price of $0.0001
- The RSUs become exercisable on January 7, 2026, and expire on July 7, 2030
Important correction note: The filing indicates that the RSU shares were issued in error and were subsequently returned to the issuer under Rule 16b-3(e).
This Form 4/A is an amended insider trading report for Jeffrey M. Jagid, who serves as both Director and Chief Executive Officer of Atlantic International Corp (ATLN). The filing corrects a previously reported transaction from January 2024.
Key transaction details:
- Acquired 2,885,856 shares of common stock at $0.0001 per share on January 2, 2024
- Total beneficial ownership following transaction: 3,735,169 shares (Direct ownership)
- Received 2,885,856 Restricted Stock Units (RSUs) on January 7, 2025
- Exercisable from January 2, 2026
- Expiration date: July 2, 2030
Important correction note: The filing indicates that the RSUs were issued in error and were subsequently returned to the issuer under Rule 16b-3(e).
This Form 4/A is an amended insider trading report for Michael Tenore, General Counsel of Atlantic International Corp (ATLN), correcting a filing from January 8, 2025. The amendment addresses transactions that occurred on January 7, 2025.
Key transaction details:
- Acquired 577,171 shares of common stock at $0.0001 per share
- Received 577,171 Restricted Stock Units (RSUs) with exercise price of $0.0001
- RSUs are exercisable from January 7, 2026, with expiration on July 7, 2030
- Total direct ownership after transactions: 1,001,634 shares
Important correction note: The filing indicates that the RSU shares were issued in error and subsequently returned to the issuer under Rule 16b-3(e). This amendment appears to be correcting this erroneous issuance.
FAQ
What is the current stock price of Atlantic Intl (ATLN)?
What is the market cap of Atlantic Intl (ATLN)?
